Click here to view the Cigna Medical Policy Updates » Catch Up On The Latest…
Medical Mutual of Ohio Medical Policy Updates – October 2018
Click here to view the Medical Mutual of Ohio Medical Policy Updates »
October 2018 Medical Policy Updates:
- Actemra SC (tocilizumab)
- Benlysta (belimumab injection for subcutaneous use)
- Breast Reconstruction and Related Procedures
- Calcitonin Gene-Related Peptide (CGRP) Antagonist
- Cimzia (certolizumab pegol for subcutaneous [SC] injection [lyophilized] and SC injection [solution] −UCB)
- Colony Stimulating Factors Granix™ (tbo-filgrastim)
- Colony Stimulating Factors Neupogen® (filgrastim)
- Crysvita® (burosumab-twza) Ryplazim™ (plasminogen)
- Entyvio (vedolizumab injection for intravenous [IV] use–Takeda Pharmaceuticals America, Inc.)
- Erythroid Stimulating Agents – Epoetin Alfa Products
- Erythropoiesis Stimulating Agents
- Exondys 51 ™ (eteplirsen infusion)
- Functional Electrical Stimulation (FES) and Neuromuscular electrical stimulators (NMES)
- Genetic Testing and Genetic Counseling General
- Hyaluronic acid derivatives, intraarticular
- Imlygic (talimogene laherparepvec )
- Immune globulin intravenous (IVIG)
- Immune Globulins Subcutaneous (SCIG)
- Intensity Modulated Radiation Therapy
- Investigational Experimental Services Not Eligible for Reimbursement
- Keytruda (pembrolizumab for injection, intravenous use)
- Light Therapies for Dermatological Conditions
- Mircera (methoxy polyethylene glycol-epoetin beta injection)
- Nplate (romiplostim for subcutaneous injection)
- Oncology Medications
- Onpattro (Patisiran)
- Opdivo (nivolumab injection for intravenous use)
- Ophthalmic Vascular Endothelial Growth Factor (VEGF) Inhibitor Injectable Drugs for Macular Degeneration
- Parsabiv (etelcalcetide)
- Poteligeo (mogamulizumab-kpkc)
- Pulmonary Arterial Hypertension (PAH) Epoprostenol for intravenous injection (Flolan , Veletri , generics)
- Remicade (infliximab for intravenous [IV] injection) Inflectra (infliximab-dyyb for intravenous [IV] injection)
- Rituxan Hycela (rituximab and hyaluronidase human injection for subcutaneous use )
- Ruconest (recombinant C1 esterase inhibitor for IV use – Salix Pharmaceuticals)
- Synribo (omacetaxine mepesuccinate)
- Takhzyro (Lanadelumab-flyo)
- Transcranial Magnetic Stimulation
- Tysabri (natalizumab)
- Vectibix (panitumumab solution for intravenous [IV] infusion )
Click here to view the Medical Mutual of Ohio Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
